Abstract
Recent HIV treatment guidelines advocating earlier initiation of antiretroviral therapy (ART) will, if followed, increase the number of patients eligible to receive costly medications. Appropriate resource allocation for this situation will require reliable studies of the natural history of HIV infection. To that end, researchers recently evaluated the time from HIV seroconversion to various CD4-cell-count thresholds, using data from CASCADE, an international collaboration of 25 cohorts of individuals …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
